Numan

London, United Kingdom · Founded 2018 · Privately Held (backing)

Operator of a digital healthcare platform intended to address weight loss, erectile dysfunction and other health conditions. Numan is based in London, United Kingdom and was founded in 2018. Its last reported valuation was $201 million in Jul 2021. It has raised $86.4 million.

Last reported valuation
$200.7M
Oct 2026
Priced at
—
Total raised
$86.4M
Last round
—
No prints on record

No secondary trades in Numan shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Numan with a free account
  • ·The complete investor list: 17 names
  • ·Everyone on the team, board and advisors included
  • ·Watch Numan: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Where Numan prices come from

Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Numan stock.